DexCom Aktie
WKN: A0D9T1 / ISIN: US2521311074
29.09.2023 14:30:00
|
Dexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4:30 p.m. Eastern Time.
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2023 financial results after market close on Thursday, October 26, 2023. Management will hold a conference call to review the company's third quarter 2023 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom investor relations website at investors.dexcom.com and will be archived there for future reference.
To listen to the conference call, please dial (888) 414-4585 (US/Canada) or (646) 960-0331 (International) and use the confirmation ID "9430114" approximately five minutes prior to the start time.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of health through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information about Dexcom CGM, visit www.dexcom.com.
Category: IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20230929896067/en/

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DexCom Inc.mehr Nachrichten
01.07.25 |
NASDAQ Composite aktuell: So steht der NASDAQ Composite nachmittags (finanzen.at) | |
01.07.25 |
Zuversicht in New York: S&P 500 liegt am Nachmittag im Plus (finanzen.at) | |
01.07.25 |
Dienstagshandel in New York: So entwickelt sich der NASDAQ 100 aktuell (finanzen.at) | |
01.07.25 |
NASDAQ Composite Index-Titel DexCom-Aktie: So viel hätte eine Investition in DexCom von vor 5 Jahren gekostet (finanzen.at) | |
01.07.25 |
NASDAQ-Handel NASDAQ 100 präsentiert sich zum Start leichter (finanzen.at) | |
01.07.25 |
S&P 500-Handel aktuell: S&P 500 verbucht zum Start Verluste (finanzen.at) | |
01.07.25 |
Zurückhaltung in New York: NASDAQ Composite verliert zum Start (finanzen.at) | |
25.06.25 |
Zuversicht in New York: NASDAQ 100 steigt letztendlich (finanzen.at) |
Analysen zu DexCom Inc.mehr Analysen
Aktien in diesem Artikel
DexCom Inc. | 70,76 | -0,80% |
|